US health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices.

While neither warning is classified as a recall, the FDA has provided additional information for the two products. Boston ...

The FDA is reviewing Boston Scientific's defibrillator leads after reports of rising shock impedance and 16 related deaths.

The update covers devices used in procedures to implant the company’s Watchman heart device.

The FDA has issued an early communication to warn of updated instructions for use for certain Boston Scientific Watchman access systems.

Key Takeaways Two Boston Scientific heart devices have been linked to serious injuries and deathsOne device may fail to ...

The FDA has issued an alert regarding a safety concern with certain Boston Scientific defibrillator leads used in implantable cardioverter defibrillators. The affected models include Endotak Reliance, ...

Boston Scientific faces scrutiny as the FDA issues warnings on two heart devices linked to injuries and deaths. The agency ...

Vinay Prasad, the top deputy to FDA chief Marty Makary, is out after less than three months at the agency.

Boston Scientific’s AI leadership, global growth, and strong R&D make it a long-term winner despite valuation and regulatory risks. See why BSX stock is a buy.